Vaccines are absolutely crucial for maintaining global health, but are a challenge to develop and...
GE Healthcare (GEHC) and the National Institute of Bioprocessing Research and Training (NIBRT) in Dublin, Ireland are partnering to combine their expertise to deliver educational programming on biopharmaceutical and cell therapy development and manufacturing.
As part of the collaboration, GE Healthcare and NIBRT will share programming, including GE Healthcare’s Fast Trak training and education curriculum, as well as co-develop a new curriculum designed to help the global biomanufacturing industry meet the needs of changing technologies and modalities.
Umay Saplakoglu, General Manager Fast Trak, GE Healthcare Life Sciences, said: “With the unprecedented growth of the novel molecules market, attracting and retaining talent with a passion for bioprocess is crucial. Our main drives are to support learning and enable access to new therapies in all parts of the world.”
Ireland is now home to all ten of the top ten world’s pharmaceutical companies and has seen approximately $10 billion invested in new biopharmaceutical facilities over the past decade. NIBRT has been pivotal in supporting the growth of the biotech talent in the Life Sciences sector, which employs 30,000 people in the country.
Killian O’Driscoll, Director of Projects, NIBRT, said: “At NIBRT, we pride ourselves on our best-in-class education and training programs that support the thriving biopharmaceutical industry. By working with GEHC we will be able to leverage their biomanufacturing expertise to create exciting new programs designed to meet the global demand for talent.”
The GEHC and NIBRT co-developed curriculum will include single-use applications training, cell therapy technology, process efficiency strategies, process development methodologies, and chromatography proficiency. Courses will be offered at GEHC Fast Trak locations, the NIBRT facility in Dublin, Ireland and the Jefferson Institute of Bioprocessing in Philadelphia.
GEHC has Fast Trak centres in South Korea, the USA, Sweden, India, and China and satellite Fast Trak Centres in Turkey, Japan and Singapore. The centres are equipped with the latest technologies for bioprocessing in an environment and at a scale that closely replicates the real-life industrial setting.
GE Healthcare supports specialised training through its collaborations:
• In July 2019, GE Healthcare and University of Technology Sydney announced the opening of the first Australian bioprocessing training-GMP Lite Facility, which provides scale-up facilities to the Australian biotech community and enables new biotech discoveries.
• In August 2018, GEHC and the Swedish Government opened Testa Center in Uppsala, a facility where academia and the industry can test and evaluate biological innovations. The centre offers bioprocess training and education.
• In June 2017, GEHC and NIBRT opened a single-use training centre at the NIBRT facility in Dublin. In 2018, NIBRT delivered approximately 18,300 training days to 4,300 trainees.
For more information on the products and services GEHC provide, please fill out the enquiry form attached to this page.
Akeso Pharmaceuticals, a biotech company that focuses in the growth and commercialisation of innovative biologics,...
When you partner with GE Healthcare’s Life Sciences you get access to a wide selection...
The biopharmaceutical industry has a reputation for being averse to change. This is likely because...